OOIR: Observatory of International Research

Papers

(The TQCC of Rheumatic Disease Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Copyright	104
Advancing Gastrointestinal Microbiota Research in Systemic Sclerosis	85
The Current Status of Exercise Applications as Medicine in Myositis Diseases on Behalf of MIHRA ICERS and MIHRA Clinical Trial Sites Network	53
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	36
Pediatric Rheumatology Comes of Age: Part II	33
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	22
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	22
Contents	22
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	19
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	16
Osteoarthritis Treatment Guidelines from Six Professional Societies	16
Exploring the Mucosal Immune Response in Axial Spondyloarthritis Through Immunoglobulin A-Coated Microbiota	15
Copyright	13
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	12
Forthcoming Issues	12
COPA Syndrome from Diagnosis to Treatment	12
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	12
Lessons Learned from the COVID-19 Pandemic in Rheumatology	11
Imaging Challenges and Developments in Large-vessel Vasculitis	11
The Short and Long of COVID-19	11
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	11
Newer Immunosuppressants for Rheumatologic Disease	10
Contributors	10
Taxonomy of Quality of Care Indicators	10
The Utility of Laboratory Investigations for the Assessment and Management of Rheumatic Immune Related Adverse Events	9

Pulmonary Hypertension Associated with Connective Tissue Disease	9
Copyright	8
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	8
Expanding the Treatment Team	8
Vaccinations in Patients with Rheumatic Disease	8
Primary Cardiac Involvement in Systemic Sclerosis	8
Contents	8
It Takes Oysters to Generate Pearls	8
Copyright	8
Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases	7
Charles L Christian	7
Daniel J McCarty, MD: A Giant of Rheumatology	7
Preventative Care in Scleroderma	7
Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease	7
De novo Connective Tissue Disorders as Immune-related Adverse Events	7
Scleroderma: Best Approaches to Patient Care	7
COVID-19 and Rheumatology	7
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	7
Rheumatology Pearls for the Primary Care Physician	6
E Carwile LeRoy, MD	6
Heart Failure in Rheumatic Disease	6
Cardiac MRI in Rheumatic Disease	6
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	6
The Giants of Rheumatology at Johns Hopkins: Lawrence E Shulman, MD, PhD and Mary Betty Stevens, MD	6
Imaging of Pulmonary Manifestations of Connective Tissue Disease	6
Copyright	6
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	5
Contents	5
Guideline Development and Implementation in Rheumatic Disease	5
Contributors	5
Forthcoming Issues	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Imaging of the Major Salivary Glands in Rheumatic Disease	5
The Challenges of New Biologic Therapies in Pediatrics	5
The Spectrum of Myocardial Disease in Idiopathic Inflammatory Myopathies	5
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	5
Copyright	5
Beyond Coronary Artery Disease	5
Contributors	5
A Guide to Contemporary Clinical Practice Guidelines	5
Contents	5
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	5
Myositis	5
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	4
Treatment Guidelines in Pediatric Rheumatic Diseases	4
SARS-CoV-2 Infection and COVID-19 in Children	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4
Management and Cure of Gouty Arthritis	4
Genetic Defects in Early-Onset Inflammatory Bowel Disease	4
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	4

Copyright	4
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	4
Role of Environment in Pediatric Rheumatic Diseases	4
The Role of Psychology in Pediatric Rheumatic Diseases	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Treatment Guidelines in Gout	4
Patient Engagement in Pediatric Rheumatology Research	4
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	4
Dual-Energy Computed Tomography Applications in Rheumatology	4